Six-month Glooko pilot shows increased engagement, glucose control among T2 diabetes patients

A six-month pilot program conducted by Sharp Rees-Stealy Medical Group in San Diego found that diabetes patients using Glooko’s care management platform were more engaged with their care and achieved better control of their blood glucose levels, according to a case study released by the company.

from MobiHealthNews http://ift.tt/2FED0UO